The elimination rate constant (ke) represents the fraction of a drug removed from your body per unit of time, and there are three main ways to calculate it depending on what data you have. The most common formula uses half-life: ke = 0.693 ÷ half-life. But you can also calculate it from two blood concentration measurements or from clearance and volume of distribution. Each method gives the same result, expressed in units of inverse time (per hour, per minute, etc.).
What the Elimination Rate Constant Tells You
Before diving into formulas, it helps to understand what ke actually represents. It is a proportionality constant that connects how fast a drug leaves your body to how much drug is currently there. The relationship is straightforward: rate of elimination = amount of drug in the body × ke.
If a drug has a ke of 0.25 per hour, roughly 25% of the remaining drug is eliminated each hour. A higher ke means faster elimination, a shorter duration of action, and a steeper drop in blood concentration over time. Most drugs follow first-order kinetics, meaning the amount eliminated per hour changes as the drug level drops, but the fraction eliminated stays constant. That constant fraction is ke.
Method 1: Calculate ke From Half-Life
This is the simplest and most widely used approach. If you know a drug’s half-life (t½), the formula is:
ke = 0.693 ÷ t½
The 0.693 comes from the natural logarithm of 2 (ln 2), which reflects the mathematical relationship between exponential decay and the time it takes for a quantity to drop by half. Make sure your units are consistent. If half-life is in hours, ke will be in per hour (hr⁻¹). If half-life is in minutes, ke will be in per minute (min⁻¹).
For example, a drug with a half-life of 4 hours has a ke of 0.693 ÷ 4 = 0.173 hr⁻¹. That means about 17.3% of the remaining drug is eliminated each hour.
Method 2: Calculate ke From Two Concentration Measurements
When you have two plasma concentration readings taken at different times during the elimination phase, you can calculate ke directly without knowing the half-life first. The formula is:
ke = (ln C1 − ln C2) ÷ (T2 − T1)
Here, C1 is the earlier (higher) concentration measured at time T1, and C2 is the later (lower) concentration measured at time T2. The “ln” refers to the natural logarithm. You can also write this equivalently as:
ke = ln(C1 / C2) ÷ (T2 − T1)
Suppose a patient’s blood level is 20 mg/L at 2 hours after a dose and 5 mg/L at 8 hours. Plugging in: ke = ln(20/5) ÷ (8 − 2) = ln(4) ÷ 6 = 1.386 ÷ 6 = 0.231 hr⁻¹. Both concentration points must fall on the elimination phase of the drug’s curve, after absorption and distribution are essentially complete. If you use points from too early in the timeline, you’ll get an inaccurate result because the drug is still distributing into tissues.
Method 3: Calculate ke From Clearance and Volume of Distribution
If you know a drug’s total body clearance (CL) and its volume of distribution (Vd), the formula is:
ke = CL ÷ Vd
Clearance describes how efficiently the body removes the drug (typically in liters per hour), and volume of distribution describes how widely the drug spreads through body compartments (in liters). Dividing one by the other gives you the fractional rate of elimination.
This method is especially useful in clinical settings where clearance has been estimated from kidney function or liver function, and volume of distribution is known from population data. For instance, if a drug has a clearance of 6 L/hr and a volume of distribution of 40 L, ke = 6 ÷ 40 = 0.15 hr⁻¹.
The Graphical Approach
Pharmacokinetic studies often determine ke visually from a graph. When you plot drug concentration on a logarithmic scale against time on a linear scale (a semi-log plot), first-order elimination appears as a straight line during the terminal phase. The slope of that straight line equals negative ke.
More precisely, the relationship follows the equation: ln(Cp) = ln(C0) − ke × t, where Cp is the plasma concentration at time t and C0 is the initial concentration. This is a standard linear equation (y = b + mx) where the slope m is −ke. If you’re working with log base 10 instead of natural log, the slope equals −ke ÷ 2.303, so you’d multiply the slope by 2.303 to get ke.
In practice, you would plot several concentration-time data points, draw or calculate the best-fit line through the terminal (straight) portion, and extract the slope. This is essentially the same math as Method 2 but uses more data points for a more reliable estimate.
First-Order vs. Zero-Order Elimination
All of the formulas above assume first-order kinetics, which applies to the vast majority of drugs at therapeutic doses. In first-order elimination, the rate of drug removal is proportional to how much drug is present. Double the concentration, double the rate of elimination. The ke stays constant regardless of dose.
A small number of drugs follow zero-order kinetics, where a fixed amount of drug is eliminated per unit time regardless of concentration. Alcohol is the classic example. In zero-order elimination, the concept of a rate constant works differently: the rate of elimination equals a constant (often written as K0), and the drug level drops in a straight line on a regular (non-log) plot. You cannot use the standard ke formulas for zero-order drugs because the fractional rate of removal changes with concentration.
Some drugs switch between the two. At normal doses they follow first-order kinetics, but at very high doses the body’s elimination pathways become saturated and the drug temporarily follows zero-order kinetics. This is called Michaelis-Menten or saturation kinetics.
Factors That Change ke in Practice
The ke for any given drug is not truly fixed across all patients. It depends on how well the organs responsible for elimination are functioning. Since ke equals clearance divided by volume of distribution, anything that alters either value will shift ke.
Kidney function is the biggest variable for drugs eliminated renally. As kidney filtration declines with age, disease, or dehydration, clearance drops and ke falls, meaning the drug stays in the body longer. Liver health matters for drugs that are metabolized before excretion. Conditions like cirrhosis or significant liver inflammation can reduce metabolic clearance substantially.
Age affects ke in both directions. Newborns have immature liver and kidney function, producing lower ke values for many drugs. Elderly adults also tend toward lower ke values due to gradual organ decline. Body composition plays a role too: a drug that distributes into fat will have a larger volume of distribution in someone with higher body fat, which can lower ke even if clearance stays the same.
Drug interactions can also shift ke. If one medication inhibits the liver enzymes responsible for breaking down another, the second drug’s clearance drops and its effective ke decreases. Genetic differences in enzyme activity create similar variation between individuals.
Connecting ke to Dosing Decisions
Once you have ke, you can derive several other useful pharmacokinetic values. The most direct is half-life: t½ = 0.693 ÷ ke. You can also predict the drug concentration at any future time point using the equation: C = C0 × e^(−ke × t), where e is the base of the natural logarithm and t is the elapsed time.
This matters for determining how often a drug needs to be dosed. A drug with a high ke is eliminated quickly and typically requires more frequent dosing to maintain therapeutic levels. A drug with a low ke lingers longer and can be dosed less often, but also carries a higher risk of accumulation if doses are given too close together. In steady-state dosing, it takes approximately 4 to 5 half-lives for a drug to reach stable blood levels, and ke is the number that drives that timeline.